Literature DB >> 15277362

PCR-based haplotype determination to distinguish CYP2B6*1/*7 and *5/*6.

Yuki Futatsugawa, Takahiro Kubota, Akihiro Ishiguro, Hiroshi Suzuki, Hiroshi Ishikawa, Tatsuji Iga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15277362     DOI： 10.1373/clinchem.2004.033233

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  2 in total

Review 1.  The importance of both CYP2C19 and CYP2B6 germline variations in cyclophosphamide pharmacokinetics and clinical outcomes.

Authors:  N A Helsby; M Yong; M van Kan; J R de Zoysa; K E Burns
Journal:  Br J Clin Pharmacol       Date:  2019-07-22       Impact factor: 4.335

Review 2.  PharmVar GeneFocus: CYP2B6.

Authors:  Zeruesenay Desta; Ahmed El-Boraie; Li Gong; Andrew A Somogyi; Volker M Lauschke; Collet Dandara; Kathrin Klein; Neil A Miller; Teri E Klein; Rachel F Tyndale; Michelle Whirl-Carrillo; Andrea Gaedigk
Journal:  Clin Pharmacol Ther       Date:  2021-03-11       Impact factor: 6.903
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.